ArticleEntropy (Basel, Switzerland)2022
A Novel Lightweight Real-Time Traffic Sign Detection Integration Framework Based on YOLOv4.
Article in Entropy (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed.
- RSO-YOLO: A Real-Time Detector for Small and Occluded Objects in Autonomous Driving Scenarios.Sensors (Basel, Switzerland) · 2025Article
- A lightweight network for traffic sign detection via multiple scale context awareness and semantic information guidance.Scientific reports · 2025Article
- Object Detection, Recognition, and Tracking Algorithms for ADASs-A Study on Recent Trends.Sensors (Basel, Switzerland) · 2023Review
- Traffic Sign Recognition with Deep Learning: Vegetation Occlusion Detection in Brazilian Environments.Sensors (Basel, Switzerland) · 2023Article
- SF-YOLOv5: A Lightweight Small Object Detection Algorithm Based on Improved Feature Fusion Mode.Sensors (Basel, Switzerland) · 2022Article
- Multiscale Traffic Sign Detection Method in Complex Environment Based on YOLOv4.Computational intelligence and neuroscience · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
As a popular research direction in the field of intelligent transportation, various scholars have widely concerned themselves with traffic sign detection However, there are still some key issues that need to be further solved in order to thoroughly apply related technologies to real scenarios, such as the feature extraction scheme of traffic sign images, the optimal selection of detection methods, and the objective limitations of detection tasks. For the purpose of overcoming these difficulties, this paper proposes a lightweight real-time traffic sign detection integration framework based on YOLO by combining deep learning methods. The framework optimizes the latency concern by reducing the computational overhead of the network, and facilitates information transfer and sharing at diverse levels. While improving the detection efficiency, it ensures a certain degree of generalization and robustness, and enhances the detection performance of traffic signs in objective environments, such as scale and illumination changes. The proposed model is tested and evaluated on real road scene datasets and compared with the current mainstream advanced detection models to verify its effectiveness. In addition, this paper successfully finds a reasonable balance between detection performance and deployment difficulty by effectively reducing the computational cost, which provides a possibility for realistic deployment on edge devices with limited hardware conditions, such as mobile devices and embedded devices. More importantly, the related theories have certain application potential in technology industries such as artificial intelligence or autonomous driving.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.